Revolutionary new cancer treatments
- 4 months ago
Dendritic cell (DC) vaccine therapy.
Dendritic cells control stimulating and activating of the immune system. Dendritic cells are mixed together with peptides or tiny tumour antigens, then injected into specific parts of the body. DC-based vaccinations along with other cancer therapies offer improved treatment and survival.
CAR T-cell therapy (Killer T-cells).
Normal T-cells are taken from the patient re-engineered and laboratory grown, then injected into the patient. These new 'Killer T-cells' have surface chimeric antigen receptors (CAR's) which binds to antigens on the cancer cells surface and kills it. A truly 'seek and destroy' solution.
PIPAC (Pressurized Intraperitoneal Aerosol Chemotherapy).
PIPAC is a new chemotherapy delivery system using only 15%, of the normal radiation dose.
A nebulizer pen connected to a high-pressure injector drivs chemotherapy mist deep into the affected area. After 30 minutes the droplets are vacuumed out. This can be repeated several times until remission completes.
A far less painful and invasive method of delivering chemotherapy with minimal side effects. This is used primary for stomach or organ cancers.
The RefleXion X1.
This breakthrough technology can locate and accurately deliver radiotherapy in one session.
It turns the cancer cells into biological beacons that communicate data about their exact location. Onboard PET detectors sense this data and deliver radiotherapy to tumours with extreme accuracy. All within a tiny fraction of a second.
Dostarlimab.
A small trial at New York's Kettering Cancer Center used a drug Dostarlimab. 18 patients with rectal cancer took Dostarlimab for 6 months. In all cases the tumours completely dissapeared. The drug rather than attacking the cancer, activates the bodies own immune system to identify and kill the cancer cells.
Dendritic cells control stimulating and activating of the immune system. Dendritic cells are mixed together with peptides or tiny tumour antigens, then injected into specific parts of the body. DC-based vaccinations along with other cancer therapies offer improved treatment and survival.
CAR T-cell therapy (Killer T-cells).
Normal T-cells are taken from the patient re-engineered and laboratory grown, then injected into the patient. These new 'Killer T-cells' have surface chimeric antigen receptors (CAR's) which binds to antigens on the cancer cells surface and kills it. A truly 'seek and destroy' solution.
PIPAC (Pressurized Intraperitoneal Aerosol Chemotherapy).
PIPAC is a new chemotherapy delivery system using only 15%, of the normal radiation dose.
A nebulizer pen connected to a high-pressure injector drivs chemotherapy mist deep into the affected area. After 30 minutes the droplets are vacuumed out. This can be repeated several times until remission completes.
A far less painful and invasive method of delivering chemotherapy with minimal side effects. This is used primary for stomach or organ cancers.
The RefleXion X1.
This breakthrough technology can locate and accurately deliver radiotherapy in one session.
It turns the cancer cells into biological beacons that communicate data about their exact location. Onboard PET detectors sense this data and deliver radiotherapy to tumours with extreme accuracy. All within a tiny fraction of a second.
Dostarlimab.
A small trial at New York's Kettering Cancer Center used a drug Dostarlimab. 18 patients with rectal cancer took Dostarlimab for 6 months. In all cases the tumours completely dissapeared. The drug rather than attacking the cancer, activates the bodies own immune system to identify and kill the cancer cells.